Skip to content

Virtual Reality and Pain

Functional Outcome Response to Engaging Virtual Reality in Pediatric Patients: a Randomized Clinical Trials

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04351776
Acronym
FOREVR Peds
Enrollment
90
Registered
2020-04-17
Start date
2020-07-10
Completion date
2023-07-30
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Postoperative, Pain, Pain, Postoperative

Brief summary

Determine the impact of VR-Biofeedback, VR-distraction, and 360 video on pain and medication utilization in patients undergoing surgery; determine the role of anxiety and pain catastrophizing on changes in pain following VR-BF in patients undergoing surgery.

Interventions

Participants will be instructed which video to view

Participants will be instructed to use the Mindful Aurora application

Participants will be instructed to use one of three applications

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

90 participants assigned to one of three groups (30 participants for each group). VR- Biofeedback, VR-Distraction, 360 Video

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Ages 8 - 18 years * Able to read, understand and speak English * Patients in the immediate postoperative period with significant pain being followed by the Acute Pain Service

Exclusion criteria

* Outside the age range (\< 8 or \> 18 years) * History of developmental delays, uncontrolled psychiatric conditions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting) * History of vertigo, dizziness, and/or seizure disorder * Conditions that would preclude the application of the VR headset, such as surgeries of the head and neck

Design outcomes

Primary

MeasureTime frameDescription
Effect of VR-biofeedback on painPostoperatively 24 - 90 hours.Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Effect of VR-distraction on painPostoperatively 24 - 90 hours.Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Effect of 360 video on painPostoperatively 24 - 90 hours.Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.

Secondary

MeasureTime frameDescription
Effect of VR-distraction on medication useDuration of hospital stay up to 30 days after dischargeMedications used will be collected
Effect of 360 video on anxietyBefore 10 minute VR session.Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety
Effect of VR-biofeedback on anxietyBefore 10 minute VR session.Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Role of anxiety on changes in painOne time prior to study visitParticipants will complete a questionnaire regarding anxiety
Role of pain catastrophizingOne time prior to study visitParticipants will complete a questionnaire regarding pain
Effect of 360 video on medication useDuration of hospital stay up to 30 days after dischargeMedications used will be collected
Effect of VR-biofeedback on medication useDuration of hospital stay up to 30 days after dischargeMedications used will be collected
Effect of VR-distraction on anxietyBefore 10 minute VR session.Anxiety scores will be collected. Anxiety will be rated using a visual analog scale. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026